Physician profile
Thomas Walsh
NPI 1942664685
$12,784.01
in general payments reported to CMS, 2019-2025
50 companies · $2,602 in 2025
The $2,602 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $940 · 2021: $2,000 · 2022: $1,939 · 2023: $2,333 · 2024: $2,516 · 2025: $2,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,451.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,344.33 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Biohaven Pharmaceuticals, INC. | $1,298.60 | 2021 | |
| Novo Nordisk INC | $952.80 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $926.98 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $847.81 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $749.69 | 2021-2025 | Otezla, Repatha, Otezla |
| Pfizer INC. | $652.86 | 2021-2025 | |
| Viiv Healthcare Company | $645.69 | 2019-2024 | Apretude |
| Glaxosmithkline, LLC. | $644.39 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $561.22 | 2022-2025 | |
| Gilead Sciences, INC. | $508.06 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $393.59 | 2021-2025 | |
| Idorsia Pharmaceuticals US INC | $251.97 | 2022-2024 | Quviviq |
| Eisai INC. | $229.58 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $219.95 | 2022-2025 | Ajovy, Austedo |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $211.83 | 2021-2025 | Spravato |
| Janssen Biotech, INC. | $192.53 | 2019-2023 | Symtuza |
| Exact Sciences Corporation | $188.72 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $186.30 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.90 | 2021-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company Ltd. | $158.68 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.81 | 2021-2024 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $132.07 | 2023-2025 | Rexulti |
| Ekos Corporation | $104.00 | 2019 | |
| Insulet Corporation | $100.27 | 2025 | Omnipod |
| Currax Pharmaceuticals LLC | $98.35 | 2022-2024 | Onzetra Xsail, Contrave, Nexletol |
| Theratechnologies INC. | $94.51 | 2020 | |
| Merck Sharp & Dohme LLC | $68.53 | 2020-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $66.47 | 2025 | Caplyta |
| Jazz Pharmaceuticals INC. | $65.44 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.57 | 2021-2024 | Trintellix |
| Sumitomo Pharma America, INC. | $43.72 | 2025 | Gemtesa |
| Axsome Therapeutics, INC. | $43.42 | 2025 | Auvelity |
| Corium, LLC | $40.61 | 2024 | Azstarys |
| Sandoz INC. | $38.89 | 2025 | Hyrimoz |
| Boston Scientific Corporation | $36.25 | 2022-2023 | Watchman Access System |
| Dexcom, INC. | $35.09 | 2024-2025 | Dexcom G6 Transmitter |
| E.R. Squibb & Sons, L.L.C. | $33.95 | 2024 | Eliquis |
| Stryker Corporation | $31.99 | 2025 | Clottriever Bold Catheter |
| Ge Healthcare | $26.53 | 2025 | |
| Astellas Pharma US INC | $21.80 | 2023 | Veozah |
| Alnylam Pharmaceuticals INC. | $21.58 | 2025 | Givlaari |
| Shield Therapeutics INC | $19.73 | 2025 | |
| Tonix Medicines, INC. | $18.94 | 2025 | Tonmya |
| Lundbeck LLC | $16.05 | 2023 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $14.66 | 2024 | Zoryve |
| Emd Serono, INC. | $14.50 | 2019 | |
| Janssen Scientific Affairs, LLC | $13.62 | 2019 | |
| Paratek Pharmaceuticals, INC. | $13.26 | 2022 | |
| Biodelivery Sciences International, INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.